Research Article
Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
Table 3
Cut-off for cancer ratio (serum LDH : pleural ADA ratio).
| Cut-off level | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | PLR (95% CI) | NLR (95% CI) |
| >10 | 0.97 (0.90–0.99) | 0.26 (0.13–0.44) | 0.76 (0.67–0.84) | 0.81 (0.47–0.96) | 3.2 (2.2–4.6) | 0.22 (0.06–0.80) | >20 | 0.95 (0.87–0.98) | 0.85 (0.68–0.94) | 0.94 (0.86–0.97) | 0.87 (0.70–0.96) | 16 (6.8–37.5) | 0.13 (0.05–0.34) | >30 | 0.89 (0.80–0.94) | 0.94 (0.78–0.98) | 0.97 (0.90–0.99) | 0.78 (0.61–0.88) | 37.5 (9.5–147.3) | 0.28 (0.15–0.50) | >40 | 0.76 (0.65–0.84) | 0.94 (0.78–0.98) | 0.96 (0.88–0.99) | 0.61 (0.47–0.74) | 32 (8.1–125.3) | 0.62 (0.43–0.90) | >50 | 0.66 (0.55–0.76) | 0.94 (0.78–0.98) | 0.96 (0.87–0.99) | 0.53 (0.40–0.66) | 28 (7.1–109.3) | 0.87 (0.64–1.18) | >60 | 0.57 (0.45–0.67) | 0.97 (0.82–0.99) | 0.97 (0.87–0.99) | 0.47 (0.35–0.60) | 48 (6.8–334.1) | 1.09 (0.84–1.41) |
|
|